5 results
The current study is set up to validate the working mechanism of the current design of the FemFlow.
- To asses the safety and toxicity of peri-ablative sorafenib given in doses of either 200 mg or 400 mg twice daily.- To asses the effect of perioperative sorafenib on the RFA induced mobilization of endothelial progenitor cells and cytokines…
To evaluate the efficacy and safety of BIBF 1120 in HCC patients without prior systemic treatment as compared to Sorafenib.
Primary Objective: This study is set up to validate the patient comfort of the current design of the FemFlow. For the validation of the patient comfort, the FemFlow will be rated on:Comfort during insertion Comfort of an alien object in the bladder…
Primary objective; To asses the accuracy and precision, the criterion validity of the app compared to the goniometer and the inter and intra observer reliability Secondary objective; To evaluate the applicability of the PROSUP mobile phone…